Prestigious UK Accolade Highlights the Outstanding Innovation at the Heart of Thomson Pharma®
London, UK - April 22, 2008 -
Thomson Reuters, the world’s leading source of intelligent information
for businesses and professionals, announced that on the occasion of the
Queen’s birthday it has been awarded a Queen’s Award for Enterprise
in the Innovation category. The award acknowledges the outstanding innovation
involved in designing Thomson Pharma, the essential information
solution for the pharmaceutical industry.
Thomson Reuters was chosen to receive the award because of its innovation
in designing and developing Thomson Pharma, the comprehensive
global pharmaceutical information solution that covers the entire drug
discovery and development pipeline. Thomson Pharma delivers
customers the information they need to support every aspect of drug
research, development and commercialization — from the first actions
of drug discovery to testing, improving and launching new
drugs.
Designed over a period of
two years, Thomson Pharma had the specific goal of providing the
pharmaceutical industry with comprehensive information, drawn from more
than 40 separate sources, and delivered on a simple, flexible
fully-integrated system using cutting-edge digital technologies. Following
an intense design process which included multiple consultations with
existing and potential customers, Thomson Pharma was unveiled in
2004 to great success.
“Thomson
Pharma is helping our customers discover new opportunities and
accelerate the development of new drugs and therapies,” said Jon
Brett Harris, EVP Pharmaceutical and Chemicals Markets, Thomson Reuters.
“We are proud to be directly contributing to improving research and
development productivity and ultimately to improvements in quality of
life”.
The Scientific business of
Thomson Reuters provides information and knowledge to accelerate research,
discovery and innovation. Our authoritative, accurate and timely
information is essential for drug companies to discover new drugs and get
them to market faster; researchers to find relevant papers and know
what’s newly published in their subject; and businesses to optimize
their intellectual property and find competitive intelligence. We
create the research platforms and services of the future that will power
our customers toward business and personal success.
